Equity Profile

CVS

CVS Health Corporation

Health CareHealth Care Services$121.5B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

CVS Health Corporation is a leading health care services company that operates a chain of pharmacies and provides health care solutions. With a market cap of $121 billion, CVS plays a crucial role in the health care sector, especially as consumer spending on health services continues to grow.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and performance.

$1.85

Revenue

Total revenue reflects the overall sales performance and growth of the company.

$100.1B

Wall Street expectations, options signals, track record, and call prep available with Pro.

CVS Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+17.38%

Avg Stock Reaction

+4.06%

Last Quarter Recap

In Q1 2026, CVS reported an EPS of $2.57, exceeding expectations by 16.39%. The stock reacted positively, gaining 7.65% the next day.

Management Promises & Guidance

Continued focus on expanding health care services.
Commitment to improving pharmacy operations.
Plans to enhance digital health solutions.

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about CVS's upcoming earnings, expecting solid performance based on recent trends.

Bull Case

If CVS can maintain its strong EPS growth and exceed revenue expectations, it could signal robust demand for its health care services.

Bear Case

Concerns about rising costs and competition in the health care sector could lead to disappointing results, impacting investor sentiment.

Key Metrics to Watch

EPS

$1.85

Earnings per share is a key indicator of the company's profitability and performance.

Revenue

$100.1B

Total revenue reflects the overall sales performance and growth of the company.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will CVS achieve an EPS of $1.85 or higher this quarter?

This figure is crucial as it reflects the company's ability to generate profit amidst rising costs.

What guidance will CVS provide regarding revenue growth in health care services?

Investors will be looking for insights into future performance and the company's strategic direction.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating CVS's ability to leverage its pharmacy and health care services for higher revenue growth this quarter.

Supporting Evidence

CVS has consistently beaten EPS estimates in recent quarters, indicating strong operational performance.

The options market is pricing in a larger move than historical averages, suggesting expectations may be overly cautious.

Key Risk

If CVS can demonstrate significant growth in its health care services revenue, it could challenge current market expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating CVS's ability to maintain growth in a competitive health care landscape.

Bull Confirmed If

Achieving an EPS of $1.85 or higher with revenue exceeding $100.1B would confirm the bull case.

Bear Confirmed If

An EPS below $1.58 or revenue under $97.4B would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±7.03%

Historical Avg

±5.4%

Pricing rich

The options market is pricing in a significant move following the earnings report, indicating heightened investor uncertainty.

Options are pricing ±7.0% while CVS has averaged ±5.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

35.7%

Calls (563K)P/C Ratio: 0.42Puts (383K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If CVS beats expectations, history suggests a potential stock increase of around 4.06%, confirming strong demand.

In-Line / Cautious

If results are in line but management provides cautious commentary, the stock may react neutrally, reflecting uncertainty.

Miss

A miss could lead to a decline, with historical patterns suggesting an average drop of around 5.45%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on the expansion of CVS's health care services.
2Details on cost management strategies in the current economic environment.
3Insights into customer engagement and digital health initiatives.
4Guidance on future revenue growth and market positioning.
5Management's outlook on competitive pressures in the health care sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

DYNBMO

Dyne Therapeutics, Inc.

PreviewView

Jul27

ARLPBMO

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and performance.

$1.85

Revenue

Total revenue reflects the overall sales performance and growth of the company.

$100.1B

Wall Street expectations, options signals, track record, and call prep available with Pro.

CVS Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+17.38%

Avg Stock Reaction

+4.06%

Last Quarter Recap

In Q1 2026, CVS reported an EPS of $2.57, exceeding expectations by 16.39%. The stock reacted positively, gaining 7.65% the next day.

Management Promises & Guidance

Continued focus on expanding health care services.
Commitment to improving pharmacy operations.
Plans to enhance digital health solutions.

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about CVS's upcoming earnings, expecting solid performance based on recent trends.

Bull Case

If CVS can maintain its strong EPS growth and exceed revenue expectations, it could signal robust demand for its health care services.

Bear Case

Concerns about rising costs and competition in the health care sector could lead to disappointing results, impacting investor sentiment.

Key Metrics to Watch

EPS

$1.85

Earnings per share is a key indicator of the company's profitability and performance.

Revenue

$100.1B

Total revenue reflects the overall sales performance and growth of the company.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will CVS achieve an EPS of $1.85 or higher this quarter?

This figure is crucial as it reflects the company's ability to generate profit amidst rising costs.

What guidance will CVS provide regarding revenue growth in health care services?

Investors will be looking for insights into future performance and the company's strategic direction.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating CVS's ability to leverage its pharmacy and health care services for higher revenue growth this quarter.

Supporting Evidence

CVS has consistently beaten EPS estimates in recent quarters, indicating strong operational performance.

The options market is pricing in a larger move than historical averages, suggesting expectations may be overly cautious.

Key Risk

If CVS can demonstrate significant growth in its health care services revenue, it could challenge current market expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating CVS's ability to maintain growth in a competitive health care landscape.

Bull Confirmed If

Achieving an EPS of $1.85 or higher with revenue exceeding $100.1B would confirm the bull case.

Bear Confirmed If

An EPS below $1.58 or revenue under $97.4B would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±7.03%

Historical Avg

±5.4%

Pricing rich

The options market is pricing in a significant move following the earnings report, indicating heightened investor uncertainty.

Options are pricing ±7.0% while CVS has averaged ±5.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

35.7%

Calls (563K)P/C Ratio: 0.42Puts (383K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If CVS beats expectations, history suggests a potential stock increase of around 4.06%, confirming strong demand.

In-Line / Cautious

If results are in line but management provides cautious commentary, the stock may react neutrally, reflecting uncertainty.

Miss

A miss could lead to a decline, with historical patterns suggesting an average drop of around 5.45%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on the expansion of CVS's health care services.
2Details on cost management strategies in the current economic environment.
3Insights into customer engagement and digital health initiatives.
4Guidance on future revenue growth and market positioning.
5Management's outlook on competitive pressures in the health care sector.